Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease

Neurobiology of Aging

Volumn 34, Issue 7, 2013, Pages 1921.e9-1921.e15

  Cho, Hanna ^a   Jeon, Seun ^b   Kang, Sue J ^a   Lee, Jong Min ^b   Lee, Jae Hong ^c   Kim, Geon Ha ^a   Shin, Ji Soo ^a   Kim, Chi Hun ^a   Noh, Young ^a   Im, Kiho ^d   Kim, Sung Tae ^a   Chin, Juhee ^a   Seo, Sang Won ^a   Na, Duk L ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Cortical thickness; Early onset; Longitudinal study; Onset age

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN CORTEX; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE COURSE; EXECUTIVE FUNCTION; FEMALE; HIPPOCAMPUS; HUMAN; LANGUAGE DISABILITY; LONGITUDINAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84875841880     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.01.004     Document Type: Article

References (37)

1. Ahn H.J., Chin J., Park A., Lee B.H., Suh M.K., Seo S.W., Na D.L. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J. Korean Med. Sci. 2010, 25:1071-1076.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Publishing, Washington, DC. fourth ed.
3. Binetti G., Magni E., Padovani A., Cappa S.F., Bianchetti A., Trabucchi M. Neuropsychological heterogeneity in mild Alzheimer's disease. Dementia 1993, 4:321-326.
4. Bracco L., Gallato R., Grigoletto F., Lippi A., Lepore V., Bino G., Lazzaro M.P., Carella F., Piccolo T., Pozzilli C. Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study. Arch. Neurol. 1994, 51:1213-1219.
5. Chan D., Janssen J.C., Whitwell J.L., Watt H.C., Jenkins R., Frost C., Rossor M.N., Fox N.C. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet 2003, 362:1121-1122.
6. Drachman D.A., O'Donnell B.F., Lew R.A., Swearer J.M. The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course. Arch. Neurol. 1990, 47:851-856.
7. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 1987, 149:351-356.
8. Frisoni G.B., Pievani M., Testa C., Sabattoli F., Bresciani L., Bonetti M., Beltramello A., Hayashi K.M., Toga A.W., Thompson P.M. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007, 130:720-730.
9. Frisoni G.B., Testa C., Sabattoli F., Beltramello A., Soininen H., Laakso M.P. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J. Neurol. Neurosurg. Psychiatry 2005, 76:112-114.
10. Fujimori M., Imamura T., Yamashita H., Hirono N., Ikejiri Y., Shimomura T., Mori E. Age at onset and visuocognitive disturbances in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1998, 12:163-166.
11. Gomez-Isla T., Growdon W.B., McNamara M.J., Nochlin D., Bird T.D., Arango J.C., Lopera F., Kosik K.S., Lantos P.L., Cairns N.J., Hyman B.T. The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain 1999, 122(Pt 9):1709-1719.
12. Heyman A., Wilkinson W.E., Hurwitz B.J., Helms M.J., Haynes C.S., Utley C.M., Gwyther L.P. Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology 1987, 37:980-984.
13. Huff F.J., Growdon J.H., Corkin S., Rosen T.J. Age at onset and rate of progression of Alzheimer's disease. J. Am. Geriatr. Soc. 1987, 35:27-30.
14. Imamura T., Takatsuki Y., Fujimori M., Hirono N., Ikejiri Y., Shimomura T., Hashimoto M., Yamashita H., Mori E. Age at onset and language disturbances in Alzheimer's disease. Neuropsychologia 1998, 36:945-949.
15. Ishii K., Kawachi T., Sasaki H., Kono A.K., Fukuda T., Kojima Y., Mori E. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am. J. Neuroradiol. 2005, 26:333-340.
16. Jacobs D., Sano M., Marder K., Bell K., Bylsma F., Lafleche G., Albert M., Brandt J., Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 1994, 44:1215-1220.
17. Kang S.J., Jeong Y., Lee B.H., Baek M.J., Kwon J.C., Chin J., Na D.L. How early are initial symptoms recognized in Korean patients with Alzheimer's disease?. Int. J. Geriatr. Psychiatry 2004, 19:699-700.
18. Karas G.B., Burton E.J., Rombouts S.A., van Schijndel R.A., O'Brien J.T., Scheltens P., McKeith I.G., Williams D., Ballard C., Barkhof F. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003, 18:895-907.
19. Kemp P.M., Holmes C., Hoffmann S.M., Bolt L., Holmes R., Rowden J., Fleming J.S. Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J. Neurol. Neurosurg. Psychiatry 2003, 74:715-719.
20. Kim E.J., Cho S.S., Jeong Y., Park K.C., Kang S.J., Kang E., Kim S.E., Lee K.H., Na D.L. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005, 128:1790-1801.
21. Koedam E.L., Lauffer V., van der Vlies A.E., van der Flier W.M., Scheltens P., Pijnenburg Y.A. Early-versus late-onset Alzheimer's disease: more than age alone. J. Alzheimers Dis. 2010, 19:1401-1408.
22. Koss E., Edland S., Fillenbaum G., Mohs R., Clark C., Galasko D., Morris J.C. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: a CERAD analysis, Part XII. Neurology 1996, 46:136-141.
23. Lerch J.P., Evans A.C. Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 2005, 24:163-173.
24. Luders H., Lesser R.P., Hahn J., Dinner D.S., Morris H., Resor S., Harrison M. Basal temporal language area demonstrated by electrical stimulation. Neurology 1986, 36:505-510.
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
26. Mosconi L., Herholz K., Prohovnik I., Nacmias B., De Cristofaro M.T., Fayyaz M., Bracco L., Sorbi S., Pupi A. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve. J. Neurol. Neurosurg. Psychiatry 2005, 76:15-23.
27. Ortof E., Crystal H.A. Rate of progression of Alzheimer's disease. J. Am. Geriatr. Soc. 1989, 37:511-514.
28. Rogaeva E. The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. Neuromolecular. Med. 2002, 2:1-10.
29. Sakamoto S., Ishii K., Sasaki M., Hosaka K., Mori T., Matsui M., Hirono N., Mori E. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J. Neurol. Sci. 2002, 200:27-32.
30. Sano M., Devanand D.P., Richards M., Miller L.W., Marder K., Bell K., Dooneief G., Bylsma F.W., Lafleche G., Albert M. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch. Neurol. 1995, 52:961-966.
31. Seltzer B., Sherwin I. A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?. Arch. Neurol. 1983, 40:143-146.
32. Seo S.W., Im K., Lee J.M., Kim S.T., Ahn H.J., Go S.M., Kim S.H., Na D.L. Effects of demographic factors on cortical thickness in Alzheimer's disease. Neurobiol. Aging 2011, 32:200-209.
33. Sluimer J.D., Vrenken H., Blankenstein M.A., Fox N.C., Scheltens P., Barkhof F., van der Flier W.M. Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 2008, 70:1836-1841.
34. Snowden J.S., Stopford C.L., Julien C.L., Thompson J.C., Davidson Y., Gibbons L., Pritchard A., Lendon C.L., Richardson A.M., Varma A., Neary D., Mann D. Cognitive phenotypes in Alzheimer's disease and genetic risk. Cortex 2007, 43:835-845.
35. Wolk D.A., Dickerson B.C. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A 2010, 107:10256-10261.
36. Worsley K.J., Marrett S., Neelin P., Vandal A.C., Friston K.J., Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum. Brain Mapp. 1996, 4:58-73.
37. Worsley, K.J., Taylor, J.E., Carbonell, F. 2009. SurfStat: a Matlab toolbox for the statistical analysis of univariate and multivariate surface and volumetric data using linear mixed effects models and random field theory. 15th Annual Meeting of the Organization for Human Brain Mapping. June 18-23, San Francisco, CA.